{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF16489",
      "entity_text" : "gain",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5865",
      "entity_text" : "Prednisone",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "It seems that once UCRA patients receive treatment, MTX lowers the diversity and the inflammatory environment bringing the system back to levels characteristic of the earlier stage of the disease (NORA), while Prednisone allows for a more physiological gain of diversity and inflammatory environment, seemingly bringing the state of the GI closer to the HLT samples.",
  "reading_complete" : "2020-08-03T11:10:02Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T11:04:20Z",
  "trigger" : "allows",
  "evidence" : [ "Prednisone allows for a more physiological gain" ],
  "pmc_id" : "5111251",
  "score" : 0
}